Multiple endocrine neoplasia type 1: fresh perspective on clinical features and penetrance (Q34924827)

5 August 2017

1 reference

title

Multiple endocrine neoplasia type 1: fresh perspective on clinical features and penetrance (English)

1 reference

multiple endocrine neoplasia

5 August 2017

1 reference

multiple endocrine neoplasia type 1

inferred from title

1 reference

Matthew J Glascock

1

1 reference

PubMed ID

12356510

5 August 2017

Sally E Carty

series ordinal

2

1 reference

5 August 2017

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

11

1 reference

5 August 2017

3

1 reference

5 August 2017

143-150

1 reference

Genetic aspects of adenomatosis of endocrine glands

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

ENDOCRINE ADENOMATOSIS AND PEPTIC ULCER IN A LARGE KINDRED. INHERITED MULTIPLE TUMORS AND MOSAIC PLEIOTROPISM IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Positional cloning of the gene for multiple endocrine neoplasia-type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Multiple endocrine neoplasia syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Multiple Endocrine Neoplasia Type 1: A 10-Year Prospective Screening Study in Four Kindreds*

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Vocal cord paralysis and reoperative parathyroidectomy. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Results of heterotopic parathyroid autotransplantation: a 13-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

A new approach to parathyroidectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Intraoperative parathormone measurement in patients with multiple endocrine neoplasia type I syndrome and hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Cost effectiveness of EUS for preoperative localization of pancreatic endocrine tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Forty-year appraisal of gastrinoma. Back to the future

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Surgical management of insulinoma associated with multiple endocrine neoplasia type I

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Total pancreatectomy in the MEN-1 syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Cause of death in multiple endocrine neoplasia type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Lethality of multiple endocrine neoplasia type I

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Malignant endocrine tumors in patients with MEN 1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Results of treatment of pituitary disease in multiple endocrine neoplasia, type I.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Adrenal lesion in multiple endocrine neoplasia type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Thymic carcinoids in multiple endocrine neoplasia type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Pancreatic polypeptide is a useful plasma marker for radiographically evident pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognized?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Screening for the multiple endocrine neoplasia syndrome type I. A study of 11 kindreds in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Clinical studies of multiple endocrine neoplasia type 1 (MEN1)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Multiple endocrine syndrome type I. Clinical, laboratory findings, and management in five families

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type I.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Screening for multiple endocrine neoplasia type 1 in patients with recognized pituitary adenoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

Screening for MEN1 mutations in patients with atypical endocrine neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900031-7

7 January 2021

10.1016/S0960-7404(01)00031-7

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12356510